175 related articles for article (PubMed ID: 8847805)
1. [Multiple myeloma with double gammopathy (IgA-kappa, IgA-lambda) : induction of complete remission from plateau phase with interferon-alpha 2a therapy].
Kanoh T
Rinsho Ketsueki; 1996 Apr; 37(4):335-9. PubMed ID: 8847805
[TBL] [Abstract][Full Text] [Related]
2. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
3. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
6. [Diclonal gammopathy (IgG kappa, IgA lambda) with nephrotic syndrome terminating into IgA lambda myeloma after three years--report of a case].
Shigemi H; Murakami S; Oku N; Itoh K; Fujita N; Nakanishi S; Shimazaki C; Inoue D; Takahashi H; Nakagawa M
Rinsho Ketsueki; 1990 Feb; 31(2):209-13. PubMed ID: 2109804
[TBL] [Abstract][Full Text] [Related]
7. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
8. Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma.
Manley R; Monteath J; Patton WN
Clin Lab Haematol; 1999 Feb; 21(1):61-3. PubMed ID: 10197266
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
[TBL] [Abstract][Full Text] [Related]
10. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report.
Ham JY; Suh JS; Lee WK; Song KE
Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802
[TBL] [Abstract][Full Text] [Related]
11. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma.
New HD; Callen JP
Arch Dermatol; 2011 Mar; 147(3):323-8. PubMed ID: 21422340
[TBL] [Abstract][Full Text] [Related]
12. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
[TBL] [Abstract][Full Text] [Related]
13. IgA-lambda/IgG-kappa biclonal myeloma in which two clones proliferated in individual sites.
Ando K; Yaguchi M; Okabe S; Miyazawa K; Ohyashiki K
Intern Med; 2000 Feb; 39(2):170-5. PubMed ID: 10732840
[TBL] [Abstract][Full Text] [Related]
14. [Regression of IgA kappa monoclonal gammopathy in IgA lambda Kahler's disease].
Pasquali JL; Kummerlen C; Jeandel C; Christmann D; Storck D
Ann Med Interne (Paris); 1986; 137(7):552-4. PubMed ID: 3101567
[TBL] [Abstract][Full Text] [Related]
15. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) - Benefit for Stratification of Multiple Myeloma?].
Ščudla V; Lochaman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Klin Onkol; 2015; 28(5):359-69. PubMed ID: 26480864
[TBL] [Abstract][Full Text] [Related]
17. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
18. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
19. [Meningeal myelomatosis as an exclusive form of recurrence in a case of IgA-lambda myeloma in complete systemic remission].
Estellés Piera F; Gómez Codina J; Munárriz Gandía B; Maestu Maiques I; Montalar Salcedo J
Med Clin (Barc); 1991 Oct; 97(13):503-5. PubMed ID: 1758207
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous production of IgG lambda and IgA lambda in a clone of myeloma cells.
Maruyama Y; Sakamaki H; Yahara Y; Onozawa Y; Ozawa N; Shimizu M; Hayashi Y; Kawaguchi K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):86-92. PubMed ID: 2500824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
